Compounds > chitosan
Page last updated: 2024-08-25

chitosan and Cholangiocarcinoma

chitosan has been researched along with Cholangiocarcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Djaker, N; Khan, M; Li, X; Liu, H; Marsich, E; Sacco, P; Spadavecchia, J1
Chung, CW; Jeong, YI; Kang, DH; Kim, CH; Kim, DH; Kwak, TW; Lee, HM1
Chung, CW; Chung, KD; Jeong, YI; Kang, DH; Kim, DH1

Other Studies

3 other study(ies) available for chitosan and Cholangiocarcinoma

ArticleYear
DOTAREM (DOTA)-Gold-Nanoparticles: Design, Spectroscopic Evaluation to Build Hybrid Contrast Agents to Applications in Nanomedecine.
    International journal of nanomedicine, 2022, Volume: 17

    Topics: Animals; Chitosan; Cholangiocarcinoma; Contrast Media; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lactose; Meglumine; Metal Nanoparticles; Mice; Organometallic Compounds; Pancreatic Neoplasms; Polymers

2022
Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells.
    International journal of pharmaceutics, 2013, Sep-15, Volume: 454, Issue:1

    Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biological Transport; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Chlorophyllides; Cholangiocarcinoma; Drug Carriers; Humans; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Technology, Pharmaceutical; Ursodeoxycholic Acid

2013
Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells.
    International journal of pharmaceutics, 2012, Jan-17, Volume: 422, Issue:1-2

    Topics: Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Cholangiocarcinoma; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Humans; Nanoparticles; Nanotechnology; Necrosis; Neoplasm Invasiveness; Particle Size; Technology, Pharmaceutical; Tretinoin

2012